• eTheRNA immunotherapies and Ghent University announce mRNA Delivery Collaboration and License Agreement

    Tuesday July 13th 2021

  • Galapagos announces new data supporting rapid symptom improvement and sustained steroid-free remission with filgotinib in patients with Ulcerative Colitis

    Monday July 12th 2021

  • Bone Therapeutics appoints Anne Leselbaum, MD as Chief Medical Officer

    Monday July 12th 2021

  • Biotalys completes its €47.5m initial public offering on Euronext Brussel

    Wednesday July 7th 2021

  • Biotalys appoints Markus Heldt as Independent Director

    Tuesday July 6th 2021

  • eureKARE and DNAlytics establish partnership to develop a proprietary AI platform

    Tuesday July 6th 2021

  • AgomAb Therapeutics expands senior team with General Counsel and Head of Clinical Operations

    Friday July 2nd 2021

  • EIB boosts innovative biotech company Univercells with €30 million of European financing to support COVID-19-related projects

    Friday July 2nd 2021

  • Your news here?

  • Newton Biocapital invests in EditForce to support development of a unique DNA/RNA editing platform based on PPR protein technology

    Thursday July 1st 2021

  • Sequana Medical announces positive results from second interim analysis of North American pivotal alfapump® study (POSEIDON)

    Thursday July 1st 2021

  • Bone Therapeutics secures up to €16 million loan financing from the European Investment Bank to accelerate ongoing clinical and commercial development of innovative orthopedic treatments

    Thursday July 1st 2021


Strategic Partners